Valproic acid induces transcriptional activation of human GD3 synthase (hST8Sia I) in SK-N-BE(2)-C human neuroblastoma cells

Molecules and Cells

Volumn 27, Issue 1, 2009, Pages 113-118

  Kwon, Haw Young ^a   Dae, Hyun Mi ^a   Song, Na Ri ^a   Kim, Kyoung Sook ^a   Kim, Cheorl Ho ^b   Lee, Young Choon ^a  

^a Dong A University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Human GD3 synthase; SK N BE(2) C; Transcription factor; Valproic acid

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GANGLIOSIDE GD3; GANGLIOSIDE GD3 SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; SYNTHETASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; VALPROIC ACID; ALPHA N ACETYLNEURAMINATE ALPHA 2,8 SIALYLTRANSFERASE; ALPHA-N-ACETYLNEURAMINATE ALPHA-2,8-SIALYLTRANSFERASE; GANGLIOSIDE; GANGLIOSIDE, GD3; SIALYLTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BINDING SITE; BIOSYNTHESIS; CONTROLLED STUDY; DNA FLANKING REGION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; DNA RESPONSIVE ELEMENT; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; NEUROBLASTOMA; TUMOR CELL LINE;

CELL LINE, TUMOR; GANGLIOSIDES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; RESPONSE ELEMENTS; RNA, MESSENGER; SIALYLTRANSFERASES; TRANSCRIPTIONAL ACTIVATION; VALPROIC ACID;

EID: 62849108745     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0012-4     Document Type: Article

References (23)

1. W.D. Beecken T. Engl H. Ogbomo B. Relja J. Cinatl J. Bereiter-Hahn E. Oppermann D. Jonas R.A. Blaheta 2005 Valproic acid modulates NCAM polysialylation and polysialyl-transferase mRNA expression in human tumor cells Int. Im-munopharmacol. 5 757 769 1:CAS:528:DC%2BD2MXhtleguro%3D
2. R.A. Blaheta M. Michaelis P.H. Driever J. Cinatl Jr. 2005 Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies Med. Res. Rev. 25 383 397 15637697 1:CAS:528:DC%2BD2MXntlSktbg%3D 10.1002/med.20027 (Pubitemid 40946533)
3. G. Chen P.X. Yuan Y.M. Jiang L.D. Huang H.K. Manji 1999 Valproate robustly enhances AP-1 mediated gene expression Mol. Brain Res. 64 52 58 9889318 1:CAS:528:DyaK1MXhslanuw%3D%3D 10.1016/S0169-328X(98)00303-9 (Pubitemid 29049235)
4. F. Chen V. Castranova X. Shi 2001 New insights into the role of nuclear factor-κB in cell growth regulation Am. J. Pathol. 159 387 397 11485895 1:CAS:528:DC%2BD3MXms1WisLs%3D (Pubitemid 32751067)
5. N.K. Cheung U.M. Saarinen J.E. Neely B. Landmeier D. Donovan P.F. Coccia 1985 Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells Cancer Res. 45 2642 2649 2580625 1:CAS:528:DyaL2MXkt1Sqt78%3D
6. J. Cinatl Jr. J. Cinatl M. Scholz P.H. Driever D. Henrich H. Kabickova J.U. Vogel H.W. Doerr B. Kornhuber 1996 Antitumor activity of sodium valproate in cultures of human neuroblastoma cells Anticancer Drugs 7 766 773 8949988 10.1097/00001813-199609000-00008
7. J. Cinatl Jr. J. Cinatl P.H. Driever R. Kotchetkov P. Pouckova B. Kornhuber D. Schwabe 1997 Sodium valproate inhibits in vivo growth of human neuroblastoma cells Anticancer Drugs 8 958 963 9436639 1:CAS:528: DyaK1cXislWksg%3D%3D 10.1097/00001813-199711000-00007
8. J. Cinatl Jr. R. Kotchetkov R. Blaheta P.H. Driever J.U. Vogel J. Cinatl 2002 Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-α Int. J. Oncol. 20 97 106 11743648 1:CAS:528: DC%2BD38XlvFeitw%3D%3D
9. S. Ghosh M. Karin 2002 Missing pieces in the NF-κB puzzle Cell 109 S81 S96 11983155 1:CAS:528:DC%2BD38Xjt1equr4%3D 10.1016/S0092-8674(02)00703-1 (Pubitemid 34457854)
10. M. Gottlicher S. Minucci P. Zhu O.H. Kramer A. Schimpf S. Giavara J.P. Sleeman F. Lo Coco C. Nervi P.G. Pelicci, et al. 2001 Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J. 20 6969 6978 11742974 1:CAS:528:DC%2BD38XpsFKn 10.1093/emboj/20.24.6969 (Pubitemid 34062289)
11. A. Gratsa H.K. Rooprai J.P. Rogers K.K. Martin G.J. Pilkington 1997 Correlation of expression of NCAM and GD3 gan-glioside to motile behavior in neoplastic glia Anticancer Res. 17 4111 4118 9428343 1:CAS:528: DyaK1cXjslWqsw%3D%3D
12. N. Gurvich O.M. Tsygankova J.L. Meinkoth P.S. Klein 2004 Histone deacetylase is a target of valproic acid-mediated cellular differentiation Cancer Res. 64 1079 1086 14871841 1:CAS:528:DC%2BD2cXhtFCgsbk%3D 10.1158/0008-5472.CAN-03-0799 (Pubitemid 38176913)
13. S. Hakomori 1981 Glycosphingolipids in cellular interaction, differentiation, and oncogenesis Annu. Rev. Biochem. 50 733 764 7023369 1:CAS:528:DyaL3MXltFShsbg%3D 10.1146/annurev.bi.50.070181.003505
14. S. Hakomori Y. Igarashi 1993 Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling Adv. Lipid Res. 25 147 162 8396311 1:CAS:528:DyaK3sXmtVSitr0%3D
15. C.U. Johannessen 2000 Mechanisms of action of valproate: a commentatory Neurochem. Int. 37 103 110 10812195 1:CAS:528:DC%2BD3cXksF2gsb0%3D 10.1016/S0197-0186(00)00013-9 (Pubitemid 30254142)
16. N.Y. Kang S.K. Kang Y.C. Lee H.J. Choi Y.S. Lee S.Y. Cho Y.S. Kim J.H. Ko C.H. Kim 2006 Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-κB in regulated expression Glycobiology 16 375 389 16481330 1:CAS:528:DC%2BD28XjslKkurs%3D 10.1093/glycob/cwj087
17. N.Y. Kang C.H. Kim K.S. Kim J.H. Ko J.H. Lee Y.K. Jeong Y.C. Lee 2007 Expression of the human CMP-NeuAc: GM3 alpha2,8-sialyltransferase (GD3 synthase) gene through the NF-κB activation in human melanoma SK-MEL-2 cells Bio-chim. Biophys. Acta 1769 622 630 1:CAS:528:DC%2BD2sXhtlaltbnM
18. C.J. Phiel F. Zhang E.Y. Huang M.G. Guenther M.A. Lazar P.S. Klein 2001 Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J. Biol. Chem. 276 36734 36741 11473107 1:CAS:528:DC%2BD3MXnt1yrurw%3D 10.1074/jbc.M101287200
19. M.A. Rogawski W. Loscher 2004 The neurobiology of antiepileptic drugs Nat. Rev. Neurosci. 5 553 564 15208697 1:CAS:528:DC%2BD2cXkvF2kt7o%3D 10.1038/nrn1430
20. M.T. Stockhausen J. Sjölund C. Manetopoulos H. Axelson 2005 Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells Br. J. Cancer 92 751 759 15685243 1:CAS:528: DC%2BD2MXhsFWltrY%3D 10.1038/sj.bjc.6602309 (Pubitemid 40460614)
21. L. Svennerholm 1980 Gangliosides and synaptic transmission Adv. Exp. Med. Biol. 125 533 544 6244726 1:CAS:528:DyaL3cXhvFGjurY%3D
22. A. Varki 1993 Biological roles of oligosaccharides: all of the theories are correct Glycobiology 3 97 130 8490246 1:CAS:528:DyaK3sXlsFCju7k%3D 10.1093/glycob/3.2.97
23. P.X. Yuan L.D. Huang Y.M. Jiang J.S. Gutkind H.K. Manji G. Chen 2001 The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth J. Biol. Chem. 276 31674 31683 11418608 1:CAS:528:DC%2BD3MXms1Smsro%3D 10.1074/jbc.M104309200